Graham Capital Management, L.P. Intra Cellular Therapies, Inc. Transaction History
Graham Capital Management, L.P.
- $3.11 Billion
- Q2 2024
A detailed history of Graham Capital Management, L.P. transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 4,553 shares of ITCI stock, worth $341,975. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,553
Previous 17,107
73.39%
Holding current value
$341,975
Previous $1.18 Million
73.71%
% of portfolio
0.01%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding ITCI
# of Institutions
400Shares Held
87.2MCall Options Held
309KPut Options Held
302K-
Vanguard Group Inc Valley Forge, PA9.61MShares$722 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$475 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.72MShares$279 Million1.37% of portfolio
-
Jpmorgan Chase & CO New York, NY3.44MShares$258 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY3MShares$225 Million2.8% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $7.09B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...